The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Balancing immunity and pathology in visceral leishmaniasis
Open accessAbstract
Experimental visceral leishmaniasis (VL) caused by infection with Leishmania donovani results in the development of organ‐specific immunity in the two main target tissues of infection, the spleen and the liver. The liver is the site of an acute resolving infection associated with the development of inflammatory granulomas around infected Kupffer cells, and resistance to reinfection. Paradoxically, the spleen is an initial site for the generation of cell‐mediated immune responses, but ultimately becomes a site of parasite persistence with associated immunopathological changes. These include splenomegaly and a breakdown in tissue architecture that is postulated to contribute to the immunocompromized status of the host. The progressive development of splenic pathology is largely associated with high levels of TNF and interleukin (IL)‐10. Follicular dendritic cell (DC) networks are lost, whereas TNF mediates the destruction of marginal zone macrophages and gp38+stromal cells, and IL‐10 promotes impaired DC migration into T‐cell areas with consequent ineffective T‐cell priming. Splenic stromal cell function is also altered, promoting the selective development of IL‐10‐producing DC with immunoregulatory properties. Ultimately, a fine immunological balance determines responses that effectively promote parasite clearance in the liver and those that promote pathology in the spleen, and future investigation aims to separate these responses to offer further means of parasite control in chronically infected VL patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Structure and function of the spleen
Mebius, R. E., & Kraal, G. (2005) · Nature Reviews Immunology · doi:10.1038/nri1669 · Cited by 2,238
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
Belkaid, Y., Piccirillo, C. A., Mendez, S., Shevach, E. M., & Sacks, D. L. (2002) · Nature · doi:10.1038/nature01152 · Cited by 1,725
Drug Resistance in Leishmaniasis
Croft, S. L., Sundar, S., & Fairlamb, A. H. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.111-126.2006 · Cited by 1,663
Macrophage deactivation by interleukin 10.
Bogdan, C., Vodovotz, Y., & Nathan, C. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1549 · Cited by 1,238
Linsley, P. S., Greene, J. L., Brady, W., Bajorath, J., Ledbetter, J. A., & Peach, R. (1994) · Immunity · doi:10.1016/s1074-7613(94)80021-9 · Cited by 980
Wakkach, A., Fournier, N., Brun, V., Breittmayer, J.-P., Cottrez, F., & Groux, H. (2003) · Immunity · doi:10.1016/s1074-7613(03)00113-4 · Cited by 788
Vidal, S., Tremblay, M. L., Govoni, G., Gauthier, S., Sebastiani, G., Malo, D., Skamene, E., Olivier, M., Jothy, S., & Gros, P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.655 · Cited by 603
Scott, P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.9.3149 · Cited by 524
Zijlstra, E. E., & El-Hassan, A. M. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90218-4 · Cited by 494
Interleukin 10 production correlates with pathology in human Leishmania donovani infections.
Ghalib, H. W., Piuvezam, M. R., Skeiky, Y. A., Siddig, M., Hashim, F. A., el-Hassan, A. M., Russo, D. M., & Reed, S. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116570 · Cited by 434
Gruenheid, S., Pinner, E., Desjardins, M., & Gros, P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.717 · Cited by 428
Murray, H. W., & Nathan, C. F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.741 · Cited by 418
Cells in the Marginal Zone of the Spleen
Kraal, G. (1992) · International Review of Cytology · doi:10.1016/s0074-7696(08)62453-5 · Cited by 401
Karp, C. L., el-Safi, S. H., Wynn, T. A., Satti, M. M., Kordofani, A. M., Hashim, F. A., Hag-Ali, M., Neva, F. A., Nutman, T. B., & Sacks, D. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116372 · Cited by 340
Liew, F. Y., & O'Donnell, C. A. (1993) · Advances in Parasitology · doi:10.1016/s0065-308x(08)60208-0 · Cited by 332
Chemokines and the Homing of Dendritic Cells to the T Cell Areas of Lymphoid Organs
Cyster, J. G. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.447 · Cited by 327
Characterization of CTLA-4 structure and expression on human T cells.
Lindsten, T., Lee, K. P., Harris, E. S., Petryniak, B., Craighead, N., Reynolds, P. J., Lombard, D. B., Freeman, G. J., Nadler, L. M., Gray, G. S., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.7.3489 · Cited by 316
Körner, H., Cook, M., Riminton, D. S., Lemckert, F. A., Hoek, R. M., Ledermann, B., Köntgen, F., de St Groth, B. F., & Sedgwick, J. D. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271020 · Cited by 311
Leishmaniasis: new approaches to disease control
Davies, C. R., Kaye, P., Croft, S. L., & Sundar, S. (2003) · BMJ · doi:10.1136/bmj.326.7385.377 · Cited by 303
Gorak, P. M. A., Engwerda, C. R., & Kaye, P. M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199802)28:02<687::aid-immu687>3.0.co;2-n · Cited by 277
Self-citationIL-10 mediates susceptibility toLeishmania donovani infection
Murphy, M. L., Wille, U., Villegas, E. N., Hunter, C. A., & Farrell, J. P. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<2848::aid-immu2848>3.0.co;2-t · Cited by 275
Murray, H. W., Lu, C. M., Mauze, S., Freeman, S., Moreira, A. L., Kaplan, G., & Coffman, R. L. (2002) · Infection and Immunity · doi:10.1128/iai.70.11.6284-6293.2002 · Cited by 248
Kellermann, S., Hudak, S. A., Oldham, E. R., Liu, Y.-J., & McEvoy, L. M. (1999) · PubMed · Cited by 244
SLC11A1 (formerly NRAMP1) and disease resistance. Microreview
Blackwell, J. M., Goswami, T., Evans, C. A. W., Sibthorpe, D., Papo, N., White, J. K., Searle, S., Miller, E. N., Peacock, C. S., Mohammed, H., et al. (2001) · Cellular Microbiology · doi:10.1046/j.1462-5822.2001.00150.x · Cited by 242
The immunopathology of experimental visceral leishmaniasis
Kaye, P. M., Svensson, M., Ato, M., Maroof, A., Polley, R., Stager, S., Zubairi, S., & Engwerda, C. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00188.x · Cited by 231
Self-citationKaye, P. M., Curry, A. J., & Blackwell, J. M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.8.2763 · Cited by 223
Tissue granuloma structure‐function in experimental visceral leishmaniasis
Murray, H. W. (2001) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2001.00199.x · Cited by 211
Nolte, M. A., Beliën, J. A. M., Schadee-Eestermans, I., Jansen, W., Unger, W. W. J., van Rooijen, N., Kraal, G., & Mebius, R. E. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021801 · Cited by 209
Amprey, J. L., Im, J. S., Turco, S. J., Murray, H. W., Illarionov, P. A., Besra, G. S., Porcelli, S. A., & Späth, G. F. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040704 · Cited by 206
Kellermann, S.-A., Hudak, S., Oldham, E. R., Liu, Y.-J., & McEvoy, L. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3859 · Cited by 204
IL-12 enhances Th1-type responses in human Leishmania donovani infections.
Ghalib, H. W., Whittle, J. A., Kubin, M., Hashim, F. A., el-Hassan, A. M., Grabstein, K. H., Trinchieri, G., & Reed, S. G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4623 · Cited by 202
Murray, H. W., Stern, J. J., Welte, K., Rubin, B. Y., Carriero, S. M., & Nathan, C. F. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.7.2290 · Cited by 196
Smelt, S. C., Cotterell, S. E. J., Engwerda, C. R., & Kaye, P. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3681 · Cited by 192
Self-citationStromal Cells Direct Local Differentiation of Regulatory Dendritic Cells
Svensson, M., Maroof, A., Ato, M., & Kaye, P. M. (2004) · Immunity · doi:10.1016/j.immuni.2004.10.012 · Cited by 178
Organ-specific immune responses associated with infectious disease
Engwerda, C. R., & Kaye, P. M. (2000) · Immunology Today · doi:10.1016/s0167-5699(99)01549-2 · Cited by 175
Self-citationAto, M., Stäger, S., Engwerda, C. R., & Kaye, P. M. (2002) · Nature Immunology · doi:10.1038/ni861 · Cited by 174
Self-citationFlandin, J., Chano, F., & Descoteaux, A. (2006) · European Journal of Immunology · doi:10.1002/eji.200535079 · Cited by 173
Activation of TGF-β by Leishmania chagasi : Importance for Parasite Survival in Macrophages
Gantt, K. R., Schultz-Cherry, S., Rodriguez, N., Jeronimo, S. M. B., Nascimento, E. T., Goldman, T. L., Recker, T. J., Miller, M. A., & Wilson, M. E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2613 · Cited by 171
Taylor, A. P., & Murray, H. W. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1231 · Cited by 169
Ehlers, S. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.suppl_2.ii37 · Cited by 150
Ghosh, S. T., Bhattacharyya, S., Sirkar, M., Shankar, G., Das, T., Majumdar, D., Roy, S., & Majumdar, S. (2002) · Infection and Immunity · doi:10.1128/iai.70.12.6828-6838.2002 · Cited by 145
The dynamics of granuloma formation in experimental visceral leishmaniasis.
McElrath, M. J., Murray, H. W., & Cohn, Z. A. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.6.1927 · Cited by 144
The Importance of TGF-β in Murine Visceral Leishmaniasis
Wilson, M. E., Young, B. M., Davidson, B. L., Mente, K. A., & McGowan, S. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6148 · Cited by 144
Gasim, S., El-Hassan, A. M., Khalil, E. A. G., Ismail, A., Kadaru, A. M. Y., Kharazmi, A., & Theander, T. G. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00468.x · Cited by 143
Alexopoulou, L., Pasparakis, M., & Kollias, G. A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271018 · Cited by 141
Expression of the natural resistance gene Lsh in resident liver macrophages
Crocker, P. R., Blackwell, J. M., & Bradley, D. J. (1984) · Infection and Immunity · doi:10.1128/iai.43.3.1033-1040.1984 · Cited by 140
The importance of TGF-beta in murine visceral leishmaniasis.
Wilson, M. E., Young, B. M., Davidson, B. L., Mente, K. A., & McGowan, S. E. (1998) · PubMed · Cited by 139
Rosas, L. E., Satoskar, A. A., Roth, K. M., Keiser, T. L., Barbi, J. J., Hunter, C. A., de Sauvage, F. J., & Satoskar, A. R. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050013 · Cited by 139
Role and effect of TNF- alpha in experimental visceral leishmaniasis.
Tumang, M. C., Keogh, C. V., Moldawer, L. L., HELFGOTT, D. C., Teitelbaum, R., Hariprashad, J., & Murray, H. W. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.2.768 · Cited by 133
Blockade of CTLA-4 Enhances Host Resistance to the Intracellular Pathogen, Leishmania donovani
Murphy, M. L., Cotterell, S. E. J., Gorak, P. M. A., Engwerda, C. R., & Kaye, P. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.4153 · Cited by 133
Self-citationStäger, S., Alexander, J. K., Carter, K. C., Brombacher, F., & Kaye, P. M. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4804-4807.2003 · Cited by 130
Intradermal Infection Model for Pathogenesis and Vaccine Studies of Murine Visceral Leishmaniasis
Ahmed, S., Colmenares, M., Soong, L., Goldsmith‐Pestana, K., Munstermann, L. E., Molina, R., & McMahon‐Pratt, D. (2002) · Infection and Immunity · doi:10.1128/iai.71.1.401-410.2003 · Cited by 128
Murray, H. W., & Hariprashad, J. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.1.387 · Cited by 126
Destruction of follicular dendritic cells during chronic visceral leishmaniasis
Smelt, S. C., Engwerda, C. R., McCrossen, M., & Kaye, P. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3813 · Cited by 123
Self-citationEngwerda, C. R., Ato, M., Cotterell, S. E. J., Mynott, T. L., Tschannerl, A., Gorak‐Stolinska, P., & Kaye, P. M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64199-5 · Cited by 122
Self-citationStäger, S., Maroof, A., Zubairi, S., Sanos, S. L., Köpf, M., & Kaye, P. M. (2006) · European Journal of Immunology · doi:10.1002/eji.200635937 · Cited by 121
TGF-β Mediates CTLA-4 Suppression of Cellular Immunity in Murine Kalaazar
Gomes, N. A., Gattass, C. R., Barreto‐de‐Souza, V., Wilson, M. E., & DosReis, G. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.2001 · Cited by 118
Murray, H. W., Squires, K., Miralles, C. D., Stoeckle, M. Y., Granger, A. M., Granelli‐Piperno, A., & Bogdan, C. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.6.1858 · Cited by 117
Wilson, M. E., Sándor, M., Blum, A. M., Young, B. M., Metwali, A., Elliott, D. E., Lynch, R. G., & Weinstock, J. V. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.6.2231 · Cited by 112
Liver morphology and function in visceral leishmaniasis (Kala-azar).
Hag, I. A. E., Hashim, F. A., Toum, I. A. E., Homeida, M. M. A., ElKalifa, M., & Hassan, A. M. E. (1994) · Journal of Clinical Pathology · doi:10.1136/jcp.47.6.547 · Cited by 111
Visceral Leishmaniasis in Mice Devoid of Tumor Necrosis Factor and Response to Treatment
Murray, H. W., Jungbluth, A., Ritter, E., Montelibano, C., & Marino, M. W. (2000) · Infection and Immunity · doi:10.1128/iai.68.11.6289-6293.2000 · Cited by 111
Role and effect of IL-2 in experimental visceral leishmaniasis.
Murray, H. W., Miralles, G. D., Stoeckle, M. Y., & McDermott, D. F. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.2.929 · Cited by 110
SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan
Mohamed, H. S., Ibrahim, M. E., Miller, E. N., White, J. K., Cordell, H. J., Howson, J. M. M., Peacock, C. S., Khalil, E. A. G., Hassan, A. M. E., & Blackwell, J. M. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201089 · Cited by 106
Endogenous Interleukin‐12 Regulates Acquired Resistance in Experimental Visceral Leishmaniasis
Murray, H. W. (1997) · The Journal of Infectious Diseases · doi:10.1086/516482 · Cited by 101
Murray, H. W., Moreira, A. L., Lu, C. M., DeVecchio, J., Matsuhashi, M., Ma, X., & Heinzel, F. P. (2003) · The Journal of Infectious Diseases · doi:10.1086/376510 · Cited by 97
McDowell, M. A., Marovich, M., Lira, R., Braun, M., & Sacks, D. L. (2002) · Infection and Immunity · doi:10.1128/iai.70.8.3994-4001.2002 · Cited by 95
Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis.
VERESS, B., Omer, A., Satir, A. A., & Hassan, A. (1977) · PubMed · Cited by 92
Junghae, M., & Raynes, J. G. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.5026-5035.2002 · Cited by 90
Cotterell, S. E. J., Engwerda, C. R., & Kaye, P. M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199901)29:01<203::aid-immu203>3.0.co;2-b · Cited by 87
Self-citationLang, T., Hellio, R., Kaye, P. M., & Antoine, J.-C. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.8.2137 · Cited by 86
Zubairi, S., Sanos, S. L., Hill, S., & Kaye, P. M. (2004) · European Journal of Immunology · doi:10.1002/eji.200324021 · Cited by 83
Engwerda, C. R., Ato, M., Stäger, S., Alexander, C. E., Stanley, A. C., & Kaye, P. M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63262-2 · Cited by 82
Self-citationBertholet, S., Dickensheets, H. L., Sheikh, F. G., Gam, A. A., Donnelly, R. P., & Kenney, R. T. (2003) · Infection and Immunity · doi:10.1128/iai.71.4.2095-2101.2003 · Cited by 80
The macrophage resistance gene Lsh/Ity/Bcg
Blackwell, J. M. (1989) · Research in Immunology · doi:10.1016/0923-2494(89)90029-1 · Cited by 79
Kaye, P. M., & Bancroft, G. J. (1992) · Infection and Immunity · doi:10.1128/iai.60.10.4335-4342.1992 · Cited by 75
Murray, H. W., Flanders, K. C., Donaldson, D. D., Sypek, J. P., Gotwals, P. J., Liu, J., & Ma, X. (2005) · Infection and Immunity · doi:10.1128/iai.73.7.3903-3911.2005 · Cited by 75
Localization of Marginal Zone Macrophages Is Regulated by C-C Chemokine Ligands 21/19
Ato, M., Nakano, H., Kakiuchi, T., & Kaye, P. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.4815 · Cited by 66
Recent developments in leishmaniasis
Melby, P. C. (2002) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200210000-00005 · Cited by 58
Trez, C. D., Brait, M., Léo, O., Aebischer, T., Torrentera, F. A., Carlier, Y., & Muraille, É. (2004) · Infection and Immunity · doi:10.1128/iai.72.2.824-832.2004 · Cited by 54
White, J. K., Mastroeni, P., Popoff, J.-F., Evans, C. A., & Blackwell, J. M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904546 · Cited by 54
Rosas, L. E., Snider, H. M., Barbi, J. J., Satoskar, A. A., Lugo‐Villarino, G., Keiser, T. L., Papenfuss, T. L., Durbin, J. E., Radzioch, D., Glimcher, L. H., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.22 · Cited by 53
Perez, L. E., Chandrasekar, B., Saldarriaga, Ó. A., Zhao, W., Arteaga, L., Travi, B. L., & Melby, P. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5519 · Cited by 53
Amprey, J. L., Späth, G. F., & Porcelli, S. A. (2003) · Infection and Immunity · doi:10.1128/iai.72.1.589-592.2004 · Cited by 47
Das, G., Vohra, H., Rao, K. V. S., Saha, B., & Mishra, G. C. (1999) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1999.00486.x · Cited by 42
Gomes, N. A., Barreto‐de‐Souza, V., Wilson, M. E., & DosReis, G. A. (1998) · The Journal of Infectious Diseases · doi:10.1086/314520 · Cited by 40
Svensson, M., Zubairi, S., Maroof, A., Kazi, F., Taniguchi, M., & Kaye, P. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.11.7541-7547.2005 · Cited by 27
Cited by
Regulation of immunity during visceral Leishmania infection
Rodrigues, V., Cordeiro-da-Silva, A., Laforge, M., Silvestre, R., & Estaquier, J. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1412-x · Cited by 253
Possibilities and challenges for developing a successful vaccine for leishmaniasis
Srivastava, S., Shankar, P., Mishra, J., & Singh, S. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1553-y · Cited by 201
Tiwananthagorn, S., Iwabuchi, K., Ato, M., Sakurai, T., Kato, H., & Katakura, K. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001798 · Cited by 37
Metadata
- Authors
- Stanley, A. C., & Engwerda, C. R.
- Venue
- Immunology & Cell Biology
- Publisher
- Wiley
- Published
- 2006-12-05
- Volume
- 85
- Issue
- 2
- Pages
- 138-147
- ISSN
- 0004-945X (ISSN-L)
- 0818-9641
- 1440-1711
- OpenAlex
- W1971413150
- Cited by
- 254
- References
- 87
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.